Results 201 to 210 of about 1,229,349 (338)

The biochemistry of silicic acid [PDF]

, 1933
E. J. King, Helen Stantial, Margery Dolan   +2 more
openalex   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source

Regulation to function: A computational approach to specialized metabolism. [PDF]

PLoS Biol
Nodwell JR.
europepmc   +1 more source

CONTRIBUTIONS TO THE BIOCHEMISTRY OF IODINE

, 1920
A. T. Cameron, J. Carmichael
openalex   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

Correction: Dendritic fibrous nanosilica activated bovine excrement fiber to enhance the initial characteristics and durability of concrete. [PDF]

RSC Adv
Karimi M, Movahedifar SM, Honarbakhsh A, Nobahari M, Zhiani R.   +4 more
europepmc   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Correction to: Adipose tissue as target of environmental toxicants: focus on mitochondrial dysfunction and oxidative inflammation in metabolic dysfunction-associated steatotic liver disease. [PDF]

Mol Cell Biochem
Lolescu BM, Furdui-Linţa AV, Ilie CA, Sturza A, Zară F, Muntean DM, Blidişel A, Creţu OM.   +7 more
europepmc   +1 more source

The Pathology and Biochemistry of Gargoylism: A Report of Three Cases with a Review of the Literature

, 1952
Johnny Henderson, A. R. Macgregor, S. J. Thannhauser, Robert W. Holden   +3 more
openalex   +1 more source

THE BIOCHEMISTRY OF THE USTILAGINALES: III. THE DEGRADATION PRODUCTS AND PROOF OF THE CHEMICAL HETEROGENEITY OF USTILAGIC ACID [PDF]

, 1951
René Lemieux
openalex   +1 more source